4E Therapeutics News and Activities

4E Therapeutics is owned by Eli Lilly.

Eli Lilly is one of the...

• Forbes Global 2000 (#138);
• Fortune 500 (#67);
• Global Fortune 500 (#336);
• Russell 3000;
• S&P 500;
• TOB Iconic 10,000.

Eli Lilly is a company listed under the stock ticker LLY (US).

Eli Lilly has a direct presence in 18 countries.

Eli Lilly has 27 subsidiaries including 4E Therapeutics, Adverum Biotechnologies and Akouos.

They are in:

• Pharmaceuticals68%
• Biotechnology21%
• Other11%

Acquisition, funding and merger involving Eli Lilly.

• Eli Lilly has acquired 4E Therapeutics (posted on June 17 2026).

View the org chart displaying its 5 main executives

Most searched biographies at 4E Therapeutics

• Craig Benson, Chief Executive Officer
• Claire Aldridge, Director
• Michele Curatolo, Chief Medical Officer

Popular executive movements at Eli Lilly

• Jean Santana, who was Senior Director, Human Resources Business Partner, Manufacturing and Quality, is promoted to Senior Director, Global People Strategy, Manufacturing and Quality  (posted on May 13 2026).
• Jasmine Leong, who was Senior Director of International Market Alzheimer's Diagnostics, is promoted to Executive Director, International Brand, Alzheimer  (posted on May 4 2026).
• Fatemeh Akhlaghi has joined the company as Executive Director, Clinical Pharmacology  (posted on May 4 2026).

Click here to view some more movements at Eli Lilly

Create your alert
to follow the executive moves at 4E Therapeutics.

Eli Lilly has 2,408 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Eli Lilly has acquired 4E Therapeutics (posted on June 17 2026).
• HMNC Brain Health has just announced a $50 Million fundraising (posted on June 17 2026).
• Triveni Bio has just announced a $65 Million fundraising (posted on June 17 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Srini Akkaraju - Director at Tentarix Biotherapeutics

Learn more about the Biotechnology industry

Press releases by 4E Therapeutics

• Press Archives - 4E Therapeutics Inc

Social media about 4E Therapeutics

• 4E Therapeutics on Wikipedia, Google News & Yahoo Finance
• 4E Therapeutics on LinkedIn, X (Twitter) & YouTube